Treatment of Atopic Dermatitis With Ruxolitinib Cream (JAK1/JAK2 Inhibitor) or Triamcinolone Cream
Capsule Summary: Ruxolitinib cream improved Eczema Area Severity Index and Investigator ’s Global Assessment responses in patients with atopic dermatitis (AD), with rapid, sustained improvement in itch. Ruxolitinib cream may offer a novel and effective treatment for AD.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Brian S. Kim, Michael D. Howell, Kang Sun, Kim Papp, Adnan Nasir, Michael E. Kuligowski, INCB 18424-206 Study Investigators Source Type: research
More News: Allergy | Allergy & Immunology | Dermatitis | Dermatology | Eczema | Itchiness | Study | Triamcinolone